Inducible de novo expression of neoantigens in tumor cells and mice with NINJA
暂无分享,去创建一个
Nikhil S. Joshi | T. Jacks | P. Gokare | V. Gocheva | A. Boilève | Yisi Lu | M. Damo | Gregory P Chang | Kelli A. Connolly | E. Akama‐Garren | Gena G. Foster | Julie F. Cheung | Peter K. Cabeceiras | Brittany Fitzgerald | Can Cui | I. William | Mursal Nader | Da-Yae Lee | L. Schmidt | Josephine H. Wilson | Isabel Monroy | Alice Boileve
[1] J. Hubbell,et al. Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes , 2019, Nature Biomedical Engineering.
[2] D. Esterházy,et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses , 2019, Nature.
[3] D. Wirth,et al. Neoantigen Expression in Steady-State Langerhans Cells Induces CTL Tolerance , 2017, The Journal of Immunology.
[4] Morten Nielsen,et al. Gapped sequence alignment using artificial neural networks: application to the MHC class I system , 2016, Bioinform..
[5] Mark S. Anderson,et al. Tolerance is established in polyclonal CD4+ T cells by distinct mechanisms, according to self-peptide expression patterns , 2016, Nature Immunology.
[6] M. Merad,et al. JEDI T-cells enable targeted cell depletion and investigation of T-cell interactions with virtually any cell population , 2015, Nature Biotechnology.
[7] Nikhil S. Joshi,et al. Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses. , 2015, Immunity.
[8] H. Hauser,et al. An Inducible Transgenic Mouse Model for Immune Mediated Hepatitis Showing Clearance of Antigen Expressing Hepatocytes by CD8+ T Cells , 2013, PloS one.
[9] A. Lutterotti,et al. Antigen-Specific Tolerance by Autologous Myelin Peptide–Coupled Cells: A Phase 1 Trial in Multiple Sclerosis , 2013, Science Translational Medicine.
[10] J. Hubbell,et al. Engineering antigens for in situ erythrocyte binding induces T-cell deletion , 2012, Proceedings of the National Academy of Sciences.
[11] J. Dunne,et al. Posttranslational Modifications of Proteins in Type 1 Diabetes: The Next Step in Finding the Cure? , 2012, Diabetes.
[12] L. Sollid,et al. The Preferred Substrates for Transglutaminase 2 in a Complex Wheat Gluten Digest Are Peptide Fragments Harboring Celiac Disease T-Cell Epitopes , 2010, PloS one.
[13] C. S. Raymond,et al. ROSA26Flpo deleter mice promote efficient inversion of conditional gene traps in vivo , 2010, Genesis.
[14] A. Carrillo-Vico,et al. Contribution of Myelin Autoantigen Citrullination to T Cell Autoaggression in the Central Nervous System , 2010, The Journal of Immunology.
[15] T. Jacks,et al. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase , 2009, Nature Protocols.
[16] G. S. Hunt,et al. Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids , 2009, Proceedings of the National Academy of Sciences.
[17] T. Jacks,et al. Regulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer. , 2008, Cancer research.
[18] J. Drijfhout,et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. , 2008, The Journal of clinical investigation.
[19] W. Wurst,et al. Enhanced gene trapping in mouse embryonic stem cells , 2008, Nucleic acids research.
[20] Aaron J. Martin,et al. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms , 2008, Proceedings of the National Academy of Sciences.
[21] Nikhil S. Joshi,et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.
[22] L. Teyton,et al. Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II. , 2007, Virology.
[23] H. Fehling,et al. Faithful activation of an extra‐bright red fluorescent protein in “knock‐in” Cre‐reporter mice ideally suited for lineage tracing studies , 2007, European journal of immunology.
[24] M. Bevan,et al. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. , 2006, Immunity.
[25] D. Riethmacher,et al. An improved mouse line for Cre‐induced cell ablation due to diphtheria toxin A, expressed from the Rosa26 locus , 2006, Genesis.
[26] S. Jameson,et al. Central tolerance: learning self-control in the thymus , 2005, Nature Reviews Immunology.
[27] J. Rossjohn,et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified , 2005, The Journal of experimental medicine.
[28] Sebastian Amigorena,et al. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity , 2004, Nature Immunology.
[29] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[30] J. Myllyharju,et al. Relevance of Posttranslational Modifications for the Arthritogenicity of Type II Collagen1 , 2004, The Journal of Immunology.
[31] C. Sousa. Faculty Opinions recommendation of Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. , 2003 .
[32] J. Curtsinger,et al. Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells , 2003, The Journal of experimental medicine.
[33] G. Kollias,et al. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. , 2003, Immunity.
[34] O. Lund,et al. novel sequence representations Reliable prediction of T-cell epitopes using neural networks with , 2003 .
[35] Mark S. Anderson,et al. Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein , 2002, Science.
[36] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[37] L. Klein,et al. Sampling of complementing self‐antigen pools by thymic stromal cells maximizes the scope of central T cell tolerance , 2001, European journal of immunology.
[38] Kristin A. Hogquist,et al. Receptor editing in developing T cells , 2000, Nature Immunology.
[39] G. Fishman,et al. Conditional lineage ablation to model human diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Flavell,et al. T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance. , 1994, Current opinion in immunology.
[41] T. Schlake,et al. Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. , 1994, Biochemistry.
[42] J. Allison,et al. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.
[43] H. Pircher,et al. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice , 1991, Cell.
[44] David M. Kranz,et al. Positive and negative selection of an antigen receptor on T cells in transgenic mice , 1988, Nature.
[45] H. Boehmer,et al. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes , 1988, Nature.
[46] S. Miller,et al. Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation. , 2016, Biomaterials.